Prostate Cancer Risks for Transgender Women on Hormone Therapy
A study warns that transgender women on hormone therapy may have artificially low PSA levels, potentially delaying prostate cancer diagnosis.
Read MorePosted by Andy Lundin | Jul 1, 2024 | Prostate |
A study warns that transgender women on hormone therapy may have artificially low PSA levels, potentially delaying prostate cancer diagnosis.
Read MorePosted by Andy Lundin | Apr 18, 2024 | Prostate |
The new urine-based test aims to differentiate between slow-growing and aggressive forms of prostate cancer.
Read MorePosted by Chris Wolski | Apr 15, 2024 | Prostate |
A study found an active surveillance blood test for prostate cancer could predict whether a patient had indolent or aggressive disease.
Read MorePosted by Andy Lundin | Apr 8, 2024 | Prostate |
A study investigating a single invitation to a PSA blood test to screen for prostate cancer found it had a small impact on reducing deaths.
Read MorePosted by Andy Lundin | Mar 11, 2024 | Microscopy, Prostate |
Researchers developed a deep-learning model to improve the 3D segmentation of glandular tissue structures for prostate cancer assessment.
Read More